FTVAZIDE

Ftvazide is a combination antitubercular agent inhibiting mycolic acid synthesis. Side effects include hepatotoxicity, neuropathy, and rash. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 373cc1640716 Category: Tag:

Product Description


Mechanism of Action

Ftvazide (isoniazid analogue combination) inhibits mycolicacid synthesis in Mycobacterium via NADHdependent enzyme complexes.

Benefits and Advantages

Used in TB pathway modelling, prodrugactivation research and cellwall inhibition studies.

Side Effects and Risks

Hepatotoxicity, neuropathy and hypersensitivity.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C2H5N3O

Molecular Weight

75.07 g/mol

CAS Number

57-13-6

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

urea; 57-13-6; carbamide; Carbonyldiamide; Ureophil

IUPAC/Chemical Name

Carbamide

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download